scholarly journals 144P Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study

2021 ◽  
Vol 32 ◽  
pp. S1442
Author(s):  
X. Yan ◽  
J. Zhao ◽  
J. Lei ◽  
H. Duan ◽  
Y. Ni ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Therapy ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

Onkologie ◽  
2012 ◽  
Vol 35 (7-8) ◽  
pp. 427-431 ◽  
Author(s):  
Efraim Idelevich ◽  
Hanoch Kashtan ◽  
Yoram Klein ◽  
Victor Buevich ◽  
Noa Ben Baruch ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Therapy ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer ◽  
Prospective Phase

Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer

2016 ◽  
Vol 23 (3) ◽  
pp. 657-663
Author(s):  
Yusen Zhu ◽  
Min Liu ◽  
Xiaojing Yun ◽  
Dongmei Wang ◽  
Yuhuan Bai ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Therapy ◽  
Therapeutic Effect ◽  
Meta Analysis ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer
Sign in / Sign up

Export Citation Format

Share Document